Focusing On Medical Devices, Investigator Initiated Trials Shoolin guides sponsors to choose the model - traditional, decentralized or hybrid - that best addresses the clinical development challenges of the study, maximizing patient recruitment and retention and at the same time expanding access to diverse patient populations. We work with you to develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximize safety and efficiency and make data-driven decisions for every study.
Going further to make clinical development more inclusive and adaptive. Shoolin provides services to help life science and biopharmaceutical clients everywhere transform scientific discoveries into new treatments. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do.
Whatever the size or scope of your study, Shoolin provides the comprehensive clinical development services you need, from First-in-Human through Phase IV and post-marketing follow-through. We also have the regulatory consulting expertise, clinical trial operations management, payer and market access planning, medical communications and education capabilities to see your journey through efficiently and effectively.
Our functional and therapeutic expertise includes cardio-metabolic, oncology/hematology, infectious diseases, neurology/psychiatry, rare disease, respiratory, and biosimilars.
